Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Novartis to collaborate with IBM Watson Health for improving outcomes in advanced breast cancer

Novartis today announced a first-of-its-kind collaboration with IBM Watson Health on an initiative to optimize cancer care and improve patient outcomes.

5 Jun 2017

TSRI study reveals first-ever structure of Lassa virus protein

Before Ebola virus ever struck West Africa, locals were already on the lookout for a deadly pathogen: Lassa virus. With thousands dying from Lassa every year - and the potential for the virus to cause even larger outbreaks- researchers are committed to designing a vaccine to stop it.

1 Jun 2017

Researchers find new way to block type 1 diabetes

Researchers at The Jackson Laboratory, Cyteir Therapeutics and collaborating institutions have found a way to protect beta cells from destruction -- achieving a longtime, elusive goal that could lead to therapies preventing type 1 diabetes (T1D).

1 Jun 2017

Therapeutic small molecules safely prevent blood clots without excessive bleeding

It may be possible to disrupt harmful blood clots in people at risk for heart attack or stroke without increasing their risk of bleeding, according to a new study published in Nature Communications.

31 May 2017

Clinical trial uses small molecule to treat men with incurable prostate cancer

NewYork-Presbyterian and Weill Cornell Medicine have begun the first clinical trial in the United States that uses a small molecule to treat men with progressive prostate cancer that has spread beyond the prostate and is no longer responding to hormonal therapy.

31 May 2017

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Combining the kinase inhibitor ibrutinib with an investigational personalized cellular therapy known as CTL119 can lead to complete remission in patients with high-risk chronic lymphocytic leukemia (CLL), according to new research from the Perelman School of Medicine at the University of Pennsylvania and Penn's Abramson Cancer Center

31 May 2017

Rice University scientists develop and evaluate analogs of potent cancer fighters

Rice University scientists have developed and evaluated analogs of potent anti-tumor agents known as epothilones using designs and methods that both improve their biological properties and simplify their manufacture.

31 May 2017

Scripps scientists make important advance in HIV vaccine design

Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design. The development was possible thanks to previous studies at TSRI showing the structures of a protein on HIV’s surface, called the envelope glycoprotein. The scientists used these structures to design a mimic of the viral protein from a different HIV subtype, subtype C, which is responsible for the majority of infections worldwide.

29 May 2017

Researchers can attack cancer by working together, says UNC Charlotte professor

MUC1 is a protein present on the cells that line most organs. It lubricates and protects them. When cells become malignant, the MUC1 protein changes and signals tumor cells to multiply.

27 May 2017

TSRI scientists discover potential new therapy to stop deadly botulinum neurotoxin

Botulinum neurotoxin is probably best known to Americans as BOTOX, a cosmetic medicine, rather than as a cause of potentially dangerous foodborne illnesses.

26 May 2017

Immunotherapy can be more effective in NSCLC patients who received radiation therapy, study shows

A new study by UCLA scientists has found that the breakthrough immunotherapy drug pembrolizumab can be more effective in improving survival in people with non-small cell lung cancer (NSCLC) if they have previously received radiation therapy, compared to those without a history of radiation treatment.

25 May 2017

Trial shows promising results for new medicine in treating severe asthma patients

A trial led by a McMaster University respirology professor shows promising results for a new medicine for severe asthma patients.

25 May 2017

Study unravels mystery of how nerve cells are damaged in neurodegenerative diseases

A new study has uncovered a molecular mechanism in the prion protein, a protein responsible for neurodegenerative diseases, which may explain why nerve cells degenerate in these disorders.

25 May 2017

FAU researchers use robot technology to gain insights into development of malignant melanoma

Malignant melanoma is one of the most common and dangerous types of cancer. Researchers at Friedrich-Alexander Universität Erlangen-Nürnberg investigated how and why brown pigmented moles turn into malignant melanoma using innovative robot technology.

23 May 2017

UT Southwestern research shows potential of new DNA vaccine in preventing Alzheimer’s disease

A new DNA vaccine when delivered to the skin prompts an immune response that produces antibodies to protect against toxic proteins associated with Alzheimer's disease – without triggering severe brain swelling that earlier antibody treatments caused in some patients.

23 May 2017

Investigational biologic may reduce need for systemic corticosteroids in patients with severe asthma

An investigational biologic may reduce the need for adults with severe asthma to take an oral corticosteroid to control their asthma, according to a randomized controlled trial presented at the ATS 2017 International Conference.

22 May 2017

Complex malaria vaccine protects monkeys against virulent parasite strains

Researchers from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, modified an experimental malaria vaccine and showed that it completely protected four of eight monkeys that received it against challenge with the virulent Plasmodium falciparum malaria parasite.

22 May 2017

Researchers develop new biomedical polymer to treat atherosclerosis

Researchers at Ben-Gurion University and the Sheba Medical Center have developed a new therapy to treat atherosclerosis and prevent heart failure with a new biomedical polymer that reduces arterial plaque and inflammation in the cardiovascular system.

22 May 2017

Antibody drug conjugate could hold promise in improving treatment for childhood ALL

Researchers at The University of Manchester have discovered that a protein (5T4) found on the surface of cells contributes to chemotherapy resistance in the most common type of childhood leukaemia.

From The University of Manchester 19 May 2017

Researchers discover novel mechanism that causes malignant pleural effusion in lung cancer patients

Lung cancer patients are particularly susceptible to malignant pleural effusion, when fluid collects in the space between the lungs and the chest wall. Researchers at the Helmholtz Zentrum München, in partnership with the German Center for Lung Research, have discovered a novel mechanism that causes this to happen.

19 May 2017

Antibody News and Research

Further Reading

Novartis to collaborate with IBM Watson Health for improving outcomes in advanced breast cancer

TSRI study reveals first-ever structure of Lassa virus protein

Researchers find new way to block type 1 diabetes

Therapeutic small molecules safely prevent blood clots without excessive bleeding

Clinical trial uses small molecule to treat men with incurable prostate cancer

Combining oral drug with personalized cell therapy can lead to complete remission in CLL patients

Rice University scientists develop and evaluate analogs of potent cancer fighters

Scripps scientists make important advance in HIV vaccine design

Researchers can attack cancer by working together, says UNC Charlotte professor

TSRI scientists discover potential new therapy to stop deadly botulinum neurotoxin

Immunotherapy can be more effective in NSCLC patients who received radiation therapy, study shows

Trial shows promising results for new medicine in treating severe asthma patients

Study unravels mystery of how nerve cells are damaged in neurodegenerative diseases

FAU researchers use robot technology to gain insights into development of malignant melanoma

UT Southwestern research shows potential of new DNA vaccine in preventing Alzheimer’s disease

Investigational biologic may reduce need for systemic corticosteroids in patients with severe asthma

Complex malaria vaccine protects monkeys against virulent parasite strains

Researchers develop new biomedical polymer to treat atherosclerosis

Antibody drug conjugate could hold promise in improving treatment for childhood ALL

Researchers discover novel mechanism that causes malignant pleural effusion in lung cancer patients

How to make hybridoma-based antibody discovery more efficient eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo